Literature DB >> 15042318

Atrial fibrillation following chemotherapy for stage IIIE diffuse large B-cell gastric lymphoma in a patient with myotonic dystrophy (Steinert's disease).

Liliana Montella, Michele Caraglia, Raffaele Addeo, Raffaele Costanzo, Vincenzo Faiola, Alberto Abbruzzese, Salvatore Del Prete.   

Abstract

The authors describe the unusual association between diffuse B-cell gastric lymphoma and myotonic dystrophy, the most common form of adult muscular dystrophy, and sudden atrial fibrillation following one cycle of doxorubicin-based chemotherapy in the same patient. Atrial fibrillation or other cardiac arrhythmias are unusual complications in patients treated with chemotherapy. The cardiac toxicity intrinsically associated with the aggressive chemotherapy employed could function as a triggering factor for the arrhythmia in the predisposed myocardium of this patient.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15042318     DOI: 10.1007/s00277-004-0867-6

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  6 in total

Review 1.  Hypothesis: neoplasms in myotonic dystrophy.

Authors:  Christine M Mueller; James E Hilbert; William Martens; Charles A Thornton; Richard T Moxley; Mark H Greene
Journal:  Cancer Causes Control       Date:  2009-12       Impact factor: 2.506

Review 2.  Clinical aspects, molecular pathomechanisms and management of myotonic dystrophies.

Authors:  Giovanni Meola
Journal:  Acta Myol       Date:  2013-12

Review 3.  Myotonic Dystrophies: State of the Art of New Therapeutic Developments for the CNS.

Authors:  Genevieve Gourdon; Giovanni Meola
Journal:  Front Cell Neurosci       Date:  2017-04-20       Impact factor: 5.505

Review 4.  Animal models in studies of cardiotoxicity side effects from antiblastic drugs in patients and occupational exposed workers.

Authors:  Monica Lamberti; Giancarlo Giovane; Elpidio M Garzillo; Franca Avino; Antonia Feola; Stefania Porto; Vincenzo Tombolini; Marina Di Domenico
Journal:  Biomed Res Int       Date:  2014-02-19       Impact factor: 3.411

Review 5.  Anticancer Therapy-Induced Atrial Fibrillation: Electrophysiology and Related Mechanisms.

Authors:  Xinyu Yang; Xinye Li; Mengchen Yuan; Chao Tian; Yihan Yang; Xiaofeng Wang; Xiaoyu Zhang; Yang Sun; Tianmai He; Songjie Han; Guang Chen; Nian Liu; Yonghong Gao; Dan Hu; Yanwei Xing; Hongcai Shang
Journal:  Front Pharmacol       Date:  2018-10-16       Impact factor: 5.810

6.  Prevalence and risk factors of atrial fibrillation during lung and esophageal surgery: A Prospective observational study.

Authors:  Kangjie Xie; Wen Zhang; Jun Fang; Ye Guo; Man Fang; Zewu Ding; Yuqian Hu; Weifeng Yu; Fugui Li
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.